Anviro® (Valaciclovir – Containing Medicine)– Risk of Drug Reaction With Eosinophilia and Systemic Symptoms (Dress)

Anviro® (Valaciclovir – Containing Medicine)– Risk of Drug Reaction With Eosinophilia and Systemic Symptoms (Dress)

In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Zydus would like to inform you about the risk of drug reaction with eosinophilia and systemic symptoms (DRESS) associated with the use of Anviro® (valaciclovir) tablets.

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 23/05/2025
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance